These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 2429121

  • 1. Interaction of deoxycytidine and deoxycytidine analogs in normal and leukemic human myeloid progenitor cells.
    Grant S, Bhalla K, Gleyzer M.
    Leuk Res; 1986; 10(9):1139-46. PubMed ID: 2429121
    [Abstract] [Full Text] [Related]

  • 2. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 3. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
    Bhalla K, Cole J, MacLaughlin W, Arlin Z, Baker M, Graham G, Grant S.
    Leukemia; 1987 Dec; 1(12):814-9. PubMed ID: 2447450
    [Abstract] [Full Text] [Related]

  • 4. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 5. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
    Bhalla K, MacLaughlin W, Cole J, Arlin Z, Baker M, Graham G, Grant S.
    Blood; 1987 Aug; 70(2):568-71. PubMed ID: 3607288
    [Abstract] [Full Text] [Related]

  • 6. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Bhalla K, McCrady C.
    Leuk Res; 1991 Aug; 15(4):205-13. PubMed ID: 2030601
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S, Bhalla K, Rauscher F, Cadman E.
    Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
    [Abstract] [Full Text] [Related]

  • 8. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB, Tong WP, Chou TC.
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [Abstract] [Full Text] [Related]

  • 9. [The effects of histamine H2 receptor agonist, antagonist and antineoplastic agent on the in vitro growth of PB CFU-GM from normal individuals and HL-60 leukemia cells].
    He Q, Xu YH.
    Yao Xue Xue Bao; 1996 Feb; 31(5):340-5. PubMed ID: 9275711
    [Abstract] [Full Text] [Related]

  • 10. Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2'-deoxycytidine against human leukemic cells of different phenotype.
    Momparler RL, Onetto-Pothier N, Momparler LF.
    Leuk Res; 1990 Feb; 14(9):755-60. PubMed ID: 1700231
    [Abstract] [Full Text] [Related]

  • 11. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J.
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [Abstract] [Full Text] [Related]

  • 12. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

  • 13. Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.
    Momparler RL, Onetto-Pothier N, Bouffard DY, Momparler LF.
    Cancer Chemother Pharmacol; 1990 Mar; 27(2):141-6. PubMed ID: 2249330
    [Abstract] [Full Text] [Related]

  • 14. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C.
    Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
    [Abstract] [Full Text] [Related]

  • 15. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
    Qin T, Youssef EM, Jelinek J, Chen R, Yang AS, Garcia-Manero G, Issa JP.
    Clin Cancer Res; 2007 Jul 15; 13(14):4225-32. PubMed ID: 17634552
    [Abstract] [Full Text] [Related]

  • 16. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Boise L, Westin E, Howe C, Pettit GR, Turner A, McCrady C.
    Biochem Pharmacol; 1991 Jul 25; 42(4):853-67. PubMed ID: 1867641
    [Abstract] [Full Text] [Related]

  • 17. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
    Bhalla K, Birkhofer M, Arlin Z, Grant S, Lutzky J, Graham G.
    Leukemia; 1988 Dec 25; 2(12):810-3. PubMed ID: 3264363
    [Abstract] [Full Text] [Related]

  • 18. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM, Eliopoulos N, Momparler L, Le NL, Momparler RL.
    Cancer Gene Ther; 2001 Sep 25; 8(9):669-76. PubMed ID: 11593336
    [Abstract] [Full Text] [Related]

  • 19. Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1.
    Bhalla K, Cole J, MacLaughlin W, Baker M, Arlin Z, Graham G, Grant S.
    Blood; 1986 Nov 25; 68(5):1136-41. PubMed ID: 3464321
    [Abstract] [Full Text] [Related]

  • 20. Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cells.
    Muus P, Haanen C, Raijmakers R, de Witte T, Salden M, Wessels J.
    Semin Oncol; 1987 Jun 25; 14(2 Suppl 1):238-44. PubMed ID: 3473679
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.